SiO/sub 2/:Fe/sub 2/O/sub 3/
In vitro toxicity of Fe<sub>m</sub>O<sub>n</sub>, Fe<sub>m</sub>O<sub>n</sub>-SiO<sub>2</sub> composite, and SiO<sub>2</sub>-Fe<sub>m</sub>O<sub>n</sub> core-shell magnetic nanoparticles
... -Fe 2 O 3 . Using TEM characterization, Fe m O n -SiO 2 composite flake-like and SiO 2 -Fe m O n core-shell IONPs demonstrated spherical ...
11
Preparation of Fe<sub>3</sub>O<sub>4</sub> magnetic nanoparticles coated with gallic acid for drug delivery
... different pH levels which are similar to the pH of the stomach and the pH of the blood. Generally, the pH of the stomach varies from 1–2 to 4–5. After eating, the stomach releases proteases and hydrochloric acid ...
12
The effect of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> on immune function in normal ICR mice
... of Fe 3 O 4 (Fe 3 O 4 -MNPs) on the mice immune ...of Fe 3 O 4 -MNPs, ...of Fe 3 O 4 -MNPs for 72 hours, the peripheral T cells and the ...
7
Effect of interaction of magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> and artesunate on apoptosis of K562 cells
... phase were cultured in 96-well flat-bottomed plates in a triplicate pattern and treated with different concentrations of ART, MNPs-Fe 3 O 4 , or the copolymer of ART with MNPs- Fe 3 ...
8
Biocompatibility of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles and their cytotoxic effect on MCF-7 cells
... the Fe 3 O 4 nanoparticles were biocompatible and suitable for biomedi- cal ...The Fe 3 O 4 was treated with low temperature intermittent sterilization, and RPMI 1640 culture ...
10
Fe<sub>3</sub>O<sub>4</sub>-based PLGA nanoparticles as MR contrast agents for the detection of thrombosis
... Then, Fe 3 O 4 -PLGA or Fe 3 O 4 -PLGA-cRGD NPs at a final dosage of 1 mg lyophilized powder dissolving 1 mL phosphate- buffered saline (PBS) was administered to the rats by tail ...
14
<p>Oxygen-Ozone (O<sub>2</sub>-O<sub>3</sub>) Therapy in Peripheral Arterial Disease (PAD): A Review Study</p>
... therapy has been shown to down-regulate oxidative stress and in fl ammatory processes. Markers such as degree of monocyte activation, dityrosine, advanced glycation end products, neopterin, in fl ammatory cytokines were ...
16
Pharmacokinetic parameters and tissue distribution of magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles in mice
... After intragastric administration, 0.2–0.5 mL of blood from one mouse in each group were collected into an ethylene- diaminetetraacetic acid tube by enucleating eyeballs at the time points of zero minutes, hours 1, ...
6
Biocompatibility of Fe<sub>3</sub>O<sub>4</sub>/DNR magnetic nanoparticles in the treatment of hematologic malignancies
... membrane. Fe 3 O 4 -MNPs/DNR are mainly used for chemotherapy and thermotherapy, and may be in contact with blood directly or indirectly for a long time, so evaluation of their hemocompatibility is ...
6
<p>La<sub>2</sub>O<sub>3</sub> Nanoparticles Induce Reproductive Toxicity Mediated by the Nrf-2/ARE Signaling Pathway in Kunming Mice</p>
... erythroid 2-related factor (Nrf-2) plays a crucial role in cellular protection against oxidative damage by binding to the antioxidant response ele- ment ...La 2 O 3 NPs in ...
17
Multifunctional magnetic Fe<sub>3</sub>O<sub>4</sub> nanoparticles combined with chemotherapy and hyperthermia to overcome multidrug resistance
... the Fe 3 O 4 -MNP-DNR-5-BrTet and Fe 3 O 4 -MNP groups; karyopyknosis and karyorrhexis could be observed in the apoptotic cells, especially in the Fe 3 O 4 ...
9
Magnetic nanoparticles of Fe<sub>3</sub>O<sub>4</sub> enhance docetaxel-induced prostate cancer cell death
... MgNPs-Fe 3 O 4 (1 µ g/mL, 10 µ g/mL, or 100 µ g/mL) for 24 hours in the absence or presence of N-acetylcysteine (NAC; 10 mM) (Sigma-Aldrich Co); NAC was added 3 hours before treatment with ...
10
Synthesis of composite magnetic nanoparticles Fe<sub>3</sub>O<sub>4</sub> with alendronate for osteoporosis treatment
... Bis/Dex/Fe 3 O 4 and subjected to RF exposure. When Fe 3 O 4 was cultured with OBs and OCs under RF exposure, the cell survival rate declined to ~ ...of Fe 3 ...
12
<p>Green Synthesis of Zeolite/Fe<sub>2</sub>O<sub>3</sub> Nanocomposites: Toxicity & Cell Proliferation Assays and Application as a Smart Iron Nanofertilizer</p>
... various Fe (III) oxide nanocomposites, but expensive and hazardous raw materials or solvents are often involved, they involve dif fi cult reaction conditions, or the waste of a high level of energy involved makes ...
16
Assessing the axonal translocation of CeO<sub>2</sub> and SiO<sub>2</sub> nanoparticles in the sciatic nerve fibers of the frog: an ex vivo electrophysiological study
... Frogs (Rana ridibunda) of either sex and of the same age (ranging from 12 to 15 months), weighing 40–60 g, were used. The frogs were euthanatized (decapitated and pithed), and the sciatic nerves were dissected from the ...
8
Preparation, characterization, and cytotoxicity of CPT/Fe<sub>2</sub>O<sub>3</sub>-embedded PLGA ultrafine composite fibers: a synergistic approach to develop promising anticancer material
... (CPT/Fe 2 O 3 )-loaded poly(D,L-lactide-co-glycolide) (PLGA) composite mats to modulate the CPT release and to improve the structural integrity and antitumor activity of the released ...
12
Immobilized transferrin Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticle with high doxorubicin loading for dual-targeted tumor drug delivery
... tional Fe 3 O 4 @SiO 2 -based drug delivery system that combines three properties: magnetic targeting, TfR targeting, and high DOX ...modified Fe 3 O 4 @ SiO ...
9
Toxicity evaluation of Gd<sub>2</sub>O<sub>3</sub>@SiO<sub>2</sub> nanoparticles prepared by laser ablation in liquid as MRI contrast agents in vivo
... growth period were incubated with different concentrations of Gd-NPs (2 × phosphate buffered saline [PBS], 10 µ M, 1 µ M, and 100 nM) in DMEM (Dulbecco’s Modified Eagle’s Medium) at 37 ° C, 5% CO 2 . The ...
11
Polyetherimide-grafted Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub> nanoparticles as theranostic agents for simultaneous VEGF siRNA delivery and magnetic resonance cell imaging
... of Fe 3 O 4 @SiO 2 ...the Fe 3 O 4 @SiO 2 and Fe 3 O 4 @SiO 2 /PEI ...the Fe 3 O 4 @SiO ...
13
Biological responses to core–shell-structured Fe<sub>3</sub>O<sub>4</sub>@SiO<sub>2</sub>-NH<sub>2</sub> nanoparticles in rats by a nuclear magnetic resonance-based metabonomic strategy
... a 2-week acclimatization for Fe@Si NP intravenous adminis- tration: control group, low-dose 10 nm Fe@Si NP-exposure group (10L), low-dose 20 nm Fe@Si NP-exposure group (20L), high-dose 20 nm ...
16